Cancer Research Annual Meeting 2010  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sengupta, P. K.
Right arrow Articles by Smith, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sengupta, P. K.
Right arrow Articles by Smith, B. D.
[Cancer Research 63, 1789-1797, April 15, 2003]
© 2003 American Association for Cancer Research


Biochemistry and Biophysics

DNA Hypermethylation Near the Transcription Start Site of Collagen {alpha}2(I) Gene Occurs in Both Cancer Cell Lines and Primary Colorectal Cancers1

Pritam K. Sengupta, Erin M. Smith, Kwonseop Kim, Mary Jo Murnane and Barbara D. Smith

Departments of Biochemistry [P. K. S., E. M. S., M. J. M., B. D. S.] and Pathology [M. J. M.], Boston University School of Medicine, Boston, Massachusetts; Boston VA Medical Center, Boston, Massachusetts [P. K. S., E. M. S., B. D. S.]; Mallory Institute of Pathology, Boston Medical Center, Boston, Massachusetts [M. J. M.]; and Chonnam University, South Korea [K. K.]

Collagen production plays a significant role in tumor development, especially in breast cancer, hepatocarcinomas, and colorectal carcinoma. However, collagen production is decreased during oncogenic transformation of cells in culture. This study demonstrates that methylation of the collagen {alpha}2(I) gene transcription start site occurs frequently in human cancer cell lines (9 of 10), including breast cancer cell lines (MCF-7 and Hs578T), hepatocellular carcinoma cell lines (SNU387, SNU449, SNU398, and PLC/PRF/5), a fibrosarcoma cell line (HT1080), and colorectal carcinoma cell lines (HCT116, SW480, and SW620). In addition, the collagen gene is more methylated in colorectal cancer tissues compared with normal mucosa. The increased DNA methylation of the collagen gene in cell lines is inversely correlated with collagen mRNA steady-state levels. Most importantly, treatment of fibrosarcoma or breast carcinoma cells with a DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine, resulted in lower methylation and reactivation of the collagen gene in a dose-responsive manner. This is the first demonstration that the collagen {alpha}2(I) gene is methylated in multiple cancer cell lines correlating with loss of collagen expression and also methylated in primary cancer tissues. These data also suggest that methylation-induced repression of collagen transcription may be a frequent occurrence in cancer.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Xu, J. A. Harton, and B. D. Smith
CIITA Mediates Interferon-{gamma} Repression of Collagen Transcription through Phosphorylation-dependent Interactions with Co-repressor Molecules
J. Biol. Chem., January 18, 2008; 283(3): 1243 - 1256.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
J. A. Anderton, J. C. Lindsey, M. E. Lusher, R. J. Gilbertson, S. Bailey, D. W. Ellison, and S. C. Clifford
Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2
Neuro-oncol, January 1, 2008; 10(6): 981 - 994.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Muthusamy, S. Duraisamy, C. M. Bradbury, C. Hobbs, D. P. Curley, B. Nelson, and M. Bosenberg
Epigenetic Silencing of Novel Tumor Suppressors in Malignant Melanoma
Cancer Res., December 1, 2006; 66(23): 11187 - 11193.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Ibanez de Caceres, E. Dulaimi, A. M. Hoffman, T. Al-Saleem, R. G. Uzzo, and P. Cairns
Identification of novel target genes by an epigenetic reactivation screen of renal cancer.
Cancer Res., May 15, 2006; 66(10): 5021 - 5028.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xu, P. K. Sengupta, E. Seto, and B. D. Smith
Regulatory Factor for X-box Family Proteins Differentially Interact with Histone Deacetylases to Repress Collagen {alpha}2(I) Gene (COL1A2) Expression
J. Biol. Chem., April 7, 2006; 281(14): 9260 - 9270.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. van Doorn, W. H. Zoutman, R. Dijkman, R. X. de Menezes, S. Commandeur, A. A. Mulder, P. A. van der Velden, M. H. Vermeer, R. Willemze, P. S. Yan, et al.
Epigenetic Profiling of Cutaneous T-Cell Lymphoma: Promoter Hypermethylation of Multiple Tumor Suppressor Genes Including BCL7a, PTPRG, and p73
J. Clin. Oncol., June 10, 2005; 23(17): 3886 - 3896.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Sengupta, Y. Xu, L. Wang, R. Widom, and B. D. Smith
Collagen {alpha}1(I) Gene (COL1A1) Is Repressed by RFX Family
J. Biol. Chem., June 3, 2005; 280(22): 21004 - 21014.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.